Abstract
BackgroundThe RAPID-PsA trial (NCT01087788) has investigated the efficacy and safety of certolizumab pegol (CZP) for the treatment of patients (pts) with psoriatic arthritis (PsA). Previous reports have demonstrated CZP to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have